FL-118

N/A

Report date: 2025/01/18 20:00:05
NME

Base Information

Drug NameFL-118
Drug Alias NameFL-118FL7N-1FL7N-2FL7N-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis regulator Bcl-2 inhibitorsp53-binding protein Mdm-2 inhibitorsInduced myeloid leukemia cell differentiation protein Mcl-1 inhibitors +[7] 
TargetsApoptosis regulator Bcl-2p53-binding protein Mdm-2Induced myeloid leukemia cell differentiation protein Mcl-1 +[7] 
Therapy Area/IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic DuctalNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRoswell Park Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoswell Park Cancer Institute
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic DuctalNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A